Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
US12410477B2 · kind B2 · utility
0Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2023 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Apr 25, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides diagnostic and therapeutic targets for pulmonary disease, in particular, fibrotic lung disease. The inventors have found that a genetic variant MUC5B gene is associated with increased expression of the gene, increased risk of developing a pulmonary disease, and an improved prognosis and survival among those developing the pulmonary disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.